About
About HanaTide
An early-stage biotech company in Boone, North Carolina, developing a nano-reactor platform designed for rapid, efficient peptide coupling.
Our Story
A fundamental problem.
A nanoscale answer.
HanaTide was founded to address a fundamental challenge in peptide manufacturing: conventional synthesis can be slow, inefficient, labor-intensive, and dependent on large quantities of hazardous chemicals.
Through research into nano-scale reaction environments, the team developed Shaw NanoPure (SNaP), a proprietary nano-reactor platform designed to make peptide synthesis faster, more efficient, scalable, and sustainable.
HanaTide is now focused on advancing SNaP from laboratory proof-of-concept toward a commercially viable technology adoptable by peptide manufacturers and biotech companies.
Our Mission
A better way to make peptides,
built in Western North Carolina.
Bring peptide manufacturing to Western North Carolina and transform peptide manufacturing through innovative chemistry and nanoscale technology.
We aim to improve speed, yield, scalability, and sustainability while maintaining quality.
- Scientific rigor
- Innovation
- Efficiency
- Sustainability
- Translating research into practical manufacturing
Where the Technology Stands
In development.
Not yet commercially available.
Our technology is currently at MRL 2 and we are working toward MRL 3, using GHK as our model peptide.
SNaP is in development and not yet commercially available. We are an early-stage company seeking funding to advance the technology toward commercialization.
MRL 2 → MRL 3 · GHK model peptide
Our People
Two founders.
One platform in development.
Freedom B. Johnson, M.S.
Co-Founder & CSO
Nicholas N. Shaw, PhD
Co-Founder & CEO
Explore what SNaP could enable.
Reach out to talk about peptide manufacturing and the SNaP platform.